Search Results for "Clinical Trial Phase Iii Duodopa"
Matching Channels
ATX-MS-1467 for patients with multiple sclerosis (MS)
ATX-MS-1467 is a novel treatment that was developed with the aim of working with the immune system to treat the underlying cause of disease rather than just treating the symptoms or suppressing the...
Clinical trials involving new drugs are commonly classified into four phases. Each phase of the drug approval process is treated as a separate clinical trial. The drug-development process will norma...
Matching News
Intestinal Levodopa-Carbidopa for Parkinson’s Reduced ‘Off’ Time
Phase III data on Abbott’s Duodopa were presented at the American Academy of Neurology.
Alnylam Completes Enrollment in Phase I Clinical Trial and Initiates Phase II Clinical Trial of ...
Company to Present Data from Phase I Study Early in Third Quarter
Spectrum Pharmaceuticals Launches Lucanthone Phase 2 Clinical Trial for the Treatment of ...
Spectrum's Diversified Oncology Product Pipeline Has Record Number of 8 Clinical Studies in Advanced-Stage Phase 2 and Phase 3 Development Lucanthone is a Small Molecule Shown to Sensitize Tu...
UPDATE: Summit Corp begins dosing in Phase 1 clinical trial
Drug discovery group Summit has begun the dosing phase of a Phase 1 clinical trial of a potential antibiotic treatment for C.Difficile infections.
CTI initiates enrollment in pacritinib Phase 3 trial for myelofibrosis
Cell Therapeutics, Inc. (CTI) today announced that the Company has initiated clinical trial sites and began enrolling patients in a Phase 3 clinical trial, known as PERSIST-1 or PAC325, for pacritinib...
En Vivo presents EVP-6124 phase 2b clinical trial data
EnVivo Pharmaceuticals has presented pharmacokinetic and pharmacodynamic data along with the previously reported clinical results from its phase 2b clinical trial of EVP-6124, a new alpha-7 agonist, i...
Resverlogix initiates phase II trial of RVX-208 in pre-diabetes
Resverlogix, a Canadian clinical stage cardiovascular company, has initiated an exploratory phase II clinical trial in patients with pre-diabetes mellitus to examine the effects of RVX-208 and ApoA-I...
Transcept completes enrollment in TO-2061 Phase 2 trial on Phase 2 clinical trial
Transcept Pharmaceuticals, Inc. today announced that it has completed enrollment in its Phase 2 clinical trial evaluating TO-2061 added as adjunctive therapy for patients with obsessive compulsive dis...
Matching PubMed Articles
Randomized Phase II Trial Designs With Biomarkers.
Efficient development of targeted therapies that may only benefit a fraction of patients requires clinical trial designs that use biomarkers to identify sensitive subpopulations. Various randomized ph...
Assessing the success probability of a Phase III clinical trial based on Phase II data.
Assessing the probability that a Phase III clinical trial will demonstrate clinically relevant efficacy based on Phase II data is an important topic in clinical drug development. An accurate estimate...
Conditionally unbiased estimation in phase II/III clinical trials with early stopping for futility.
Seamless phase II/III clinical trials combine traditional phases II and III into a single trial that is conducted in two stages, with stage 1 used to answer phase II objectives such as treatment selec...
Estimation of treatment effect for the sequential parallel design.
The sequential parallel clinical trial is a novel clinical trial design being used in psychiatric diseases that are known to have potentially high placebo response rates. The design consists of an ini...
To achieve minimal inter-observer variability in assessment of spleen and liver volume changes using a novel MRI reading method in the context of a phase III clinical trial of a new therapy for Gauche...
